Flower extract of Caragana sinica. ameliorates Dss-induced ulcerative colitis by affecting TLR۴/NF-κB and TLR۴/MAPK signaling pathway in a mouse model

سال انتشار: 1400
نوع سند: مقاله ژورنالی
زبان: انگلیسی
مشاهده: 183

فایل این مقاله در 9 صفحه با فرمت PDF قابل دریافت می باشد

استخراج به نرم افزارهای پژوهشی:

لینک ثابت به این مقاله:

شناسه ملی سند علمی:

JR_IJBMS-24-5_005

تاریخ نمایه سازی: 18 اردیبهشت 1400

چکیده مقاله:

Objective(s): This study aimed to find out the protective effects and preliminary mechanisms of the flower extract of Caragana sinica (FEC) on dextran sulfate sodium salt (DSS)-induced colitis.Materials and Methods: The ulcerative colitis models of mice induced by ۳% DSS were established and treated with FEC. Body weight changes, disease activity index (DAI), colon histopathological score, anti-oxidant ability, and the level of inflammatory cytokines were determined. The expression of Toll-like receptor ۴ (TLR۴) and myeloid differentiation factor ۸۸ (MyD۸۸) were assessed in colonic tissue by immunohistochemical staining. Western blot was used to analyze the expression of TLR۴/ nuclear factor kappa-B (NF-κB) and TLR۴/ mitogen-activated protein kinase (MAPK) signaling pathway-related proteins. Results: FEC significantly prevented body weight loss and colonic shortening and reduced the disease activity index and histopathological score (p <۰.۰۵). Moreover, FEC treatment remarkably down-regulated the levels of myeloperoxidase (MPO), interleukin-۱beta (IL-۱β), tumor necrosis factor-alpha (TNF-α), and interleukin ۶ (IL-۶) and up-regulated the levels of superoxide dismutase (SOD), catalase (CAT), glutathione (GSH), and interleukin ۱۰ (IL-۱۰) in the colon of DSS mice (p <۰.۰۵). Furthermore, the expression of TLR۴/NF-κB and TLR۴/MAPK pathway-related proteins was inhibited by FEC (p <۰.۰۵). Conclusion: Our findings demonstrated that FEC could serve as a potential therapeutic agent for treatment of ulcerative colitis.

کلیدواژه ها:

Flower extract of Caragana sinica MAPKs NF ، κB TLR۴ Ulcerative colitis

نویسندگان

Ting Li

College of Chinese Medicine, Yunnan University of Chinese Medicine, Kunming, ۶۵۰۵۰۰, People’s Republic of China

Qiu-ping Zou

College of Chinese Medicine, Yunnan University of Chinese Medicine, Kunming, ۶۵۰۵۰۰, People’s Republic of China

Feng Huang

College of Chinese Medicine, Yunnan University of Chinese Medicine, Kunming, ۶۵۰۵۰۰, People’s Republic of China

Gui-guang Cheng

Yunnan Institute of Food Safety, Kunming University of Science and Technology, Kunming, ۶۵۰۵۰۰, People’s Republic of China

Ze-wei Mao

College of Chinese Medicine, Yunnan University of Chinese Medicine, Kunming, ۶۵۰۵۰۰, People’s Republic of China

Ting Wang

College of Chinese Medicine, Yunnan University of Chinese Medicine, Kunming, ۶۵۰۵۰۰, People’s Republic of China

Fa-wu Dong

College of Chinese Medicine, Yunnan University of Chinese Medicine, Kunming, ۶۵۰۵۰۰, People’s Republic of China

Bao-jing Li

College of Chinese Medicine, Yunnan University of Chinese Medicine, Kunming, ۶۵۰۵۰۰, People’s Republic of China

Hong-ping He

College of Chinese Medicine, Yunnan University of Chinese Medicine, Kunming, ۶۵۰۵۰۰, People’s Republic of China

Yan-ping Li

College of Chinese Medicine, Yunnan University of Chinese Medicine, Kunming, ۶۵۰۵۰۰, People’s Republic of China

مراجع و منابع این مقاله:

لیست زیر مراجع و منابع استفاده شده در این مقاله را نمایش می دهد. این مراجع به صورت کاملا ماشینی و بر اساس هوش مصنوعی استخراج شده اند و لذا ممکن است دارای اشکالاتی باشند که به مرور زمان دقت استخراج این محتوا افزایش می یابد. مراجعی که مقالات مربوط به آنها در سیویلیکا نمایه شده و پیدا شده اند، به خود مقاله لینک شده اند :
  • 1. Ungaro R, Mehandru S, Allen PB, Peyrin-Biroulet L, Colombel ...
  • 2. Baker KF, Isaacs JD. Novel therapies for immune-mediated inflammatory ...
  • 3. Petrakis I, Koilakou S, Masouridou K, Kollia AM. Vedolizumab ...
  • 4. Kopylov U, Boucher G, Waterman M, Rivers CR, Patel ...
  • 5. Xiao B, Merlin D. Oral colon-specific therapeutic approaches toward ...
  • 6. Yan Y, Ren FL, Wang PC, Sun Y, Xing ...
  • 7. Shimodate Y, Takanashi K, Waga E, Fujita T, Katsuki ...
  • 8. Van Assche G, Manguso F, Zibellini M, Cabriada Nuño ...
  • 9. Van Assche G, Manguso F, Zibellini M, Cabriada Nuño ...
  • 10. Meng QX, Niu Y, Niu XW, Roubin RH, Hanrahan ...
  • 11. Liang GL, Bi JB, Huang HQ, Zhang S, Hu ...
  • 12. Tai ZG, Cai L, Dai L, Sun WJ, Zhe ...
  • 13. Lee SR, Kwak JH, Kim HJ, Pyo S. Neuroprotective ...
  • 14. Cho H, Park JH, Ahn EK, Oh JS. Kobophenol ...
  • 15. Wang XP, Sun Y, Zhao Y, Ding YX, Zhang ...
  • 16. Shi Z, Li T, Liu YW, Cai TT, Yao ...
  • 17. Vázquez CV, Rojas MGV, Ramírez CA, Chávez-Servín JL, García-Gasca ...
  • 18. Alex P, Zachos NC, Nguyen T, Gonzales L, Chen ...
  • 19. Liu W, Guo WJ, Wu J, Luo Q, Tao ...
  • 20. Dou W, Zhang JJ, Zhang E, Sun A, Ding ...
  • 21. Wang RQ, Wu GT, Du LD, Shao J, Liu ...
  • 22. Pearson G, Robinson F, Beers Gibson T, Xu BE, ...
  • 23. Goyal N, Rana A, Ahlawat A, Bijjem KRV, Kumar ...
  • 24. Lebeer S, Vanderleyden J, De Keersmaecker SCJ. Host interactions ...
  • 25. Guo YL, Wu XX, Wu Q, Lu YF, Shi ...
  • 26. Zhu H, Li YR. Oxidative stress and redox signaling ...
  • 27. Rezaie A, Parker RD, Abdollahi M. Oxidative stress and ...
  • 28. Chen HL, Yang J, Fu YF, Meng XN, Zhao ...
  • 29. Strengert M, Jennings R, Davanture S, Hayes P, Gabriel ...
  • 30. Danese S, Mantovani A. Inflammatory bowel disease and intestinal ...
  • 31. Tian T, Wang ZL, Zhang JH. Pathomechanisms of oxidative ...
  • 32. Shen J, Cheng JZ, Zhu SG, Zhao J, Ye ...
  • 33. Chavan S, Sava L, Saxena V, Pillai S, Sontakke ...
  • 34. Liu G, Yu L, Fang J, Hu CAA, Yin ...
  • 35. Xu XP, Zhang L, Liu ZH, Pan Y, Chen ...
  • 36. Slattery ML, Herrick JS, Bondurant KL, Wolff RK. Toll-like ...
  • 37. Kumar H, Kawai T, Akira S. Toll-like receptors and ...
  • 38. He XX, Wei ZK, Wang JJ, Kou JH, Liu ...
  • 39. Choi YH, Bae JK, Chae HS, Choi YO, Nhoek ...
  • 40. Park JH, Peyrin-Biroulet L, Eisenhut M, Shin JI. IBD ...
  • 41. Perkins ND. Integrating cell-signalling pathways with NF-κB and IKK ...
  • 42. Oh WJ, Jung U, Eom HS, Shin HJ, Park ...
  • 43. Thalhamer T, McGrath MA, Harnett MM. MAPKs and their ...
  • 44. Li CP, Li JH, He SY, Chen O, Shi ...
  • 45. Saccani S, Pantano S, Natoli G. p38-dependent marking of ...
  • 46. Min GY, Park JM, Joo IH, Kim DH. Inhibition ...
  • 47. Wu WL, Li DY, Zong Y, Zhu H, Pan ...
  • 48. Seelinger G, Merfort I, Schempp CM. Anti-oxidant, anti-inflammatory and ...
  • 49. Han YM, Koh J, Kim JH, Lee J, Im ...
  • 50. Mascaraque C, González R, Suárez MD, Zarzuelo A, de ...
  • 51. Sun LC, Zhang HB, Gu CD, Guo SD, Li ...
  • نمایش کامل مراجع